AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Univone 1.5mg Injection

Prescription Icon
Prescription Required

Marketer

Mits Healthcare Pvt Ltd

Salt Composition

Edaravone (1.5mg)

Overview Univone 1.5mg Injection

For individuals with amyotrophic lateral sclerosis (ALS), a debilitating neurological condition causing muscle weakness and functional impairment, Univone 1.5mg Injection offers therapeutic benefits. This antioxidant medication helps mitigate nerve cell damage, thus potentially slowing ALS progression. Administered intravenously by a healthcare provider—and not for self-injection—it's indicated when oral intake is infeasible. Dosage and treatment duration should strictly adhere to your physician's instructions. Missed doses should be taken immediately upon recollection. While headache, bruising, and gait abnormalities are common side effects, localized injection site reactions (pain, redness, swelling) are also possible; these typically resolve spontaneously. However, persistent or troublesome side effects warrant medical consultation. Seek immediate medical attention should an allergic reaction (itching, facial/lip/tongue swelling) occur.

Primary Ingredients of Univone 1.5mg Injection

No information provided. Please provide the text you wish me to rewrite.

Uses of Univone 1.5mg Injection

Lou Gehrig's disease

Major Benefits of Univone 1.5mg Injection:

The medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.

Common Side effects of Univone 1.5mg Injection:

  • Bruise
  • Walking difficulties
  • Headache
  • Injection site reactions (pain, swelling, redness)

How to use Univone 1.5mg Injection:

This medication will be administered by your physician or their qualified staff. Self-medication is strongly discouraged.

How Univone 1.5mg Injection works:

Neuro-Guard 1.5mg Injection offers antioxidant, neuroprotective, and nootropic benefits. By counteracting the damaging effects of free radicals, it mitigates nerve cell deterioration. This action helps to slow the advancement of amyotrophic lateral sclerosis (ALS) symptoms through the restoration of oxidative balance within the brain.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Univone 1.5mg Injection may pose safety risks; professional medical advice is recommended.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Univone 1.5mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the safety of Univone 1.5mg Injection for breastfeeding mothers is lacking. Seek medical advice from your physician.

DrivingDrivingCONSULT YOUR DOCTOR

Driving ability while using Univone 1.5mg Injection is undetermined. Refrain from driving if any concentration or reaction-impairing symptoms arise.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Univone 1.5mg Injection to individuals with renal impairment. Seek medical advice.

LiverLiverCAUTION

Exercise caution when administering Univone 1.5mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician. Data regarding Univone 1.5mg Injection use in such patients is limited. Dosage alteration is not advised for patients exhibiting mild to moderate liver dysfunction.

What if you forget to take Univone 1.5mg Injection :

NA

Facts to Know About Univone 1.5mg Injection

LabelValue
Chemical Category Pyrazolone Derivatives
Developing Habits No.
Treatment Category Neuroscience of the Central Nervous System
Actions Cognitive enhancer

FAQs on Univone 1.5mg Injection

Univone 1.5mg Injection may cause confusion, headache, and gait disturbances. Less frequent side effects include skin rash and itching, shortness of breath, chest tightness, wheezing, cough (particularly in asthmatics), and fungal infections.
Administered by a healthcare professional in a clinical setting, Univone 1.5mg Injection is a liquid solution given intravenously over one hour. Initially, it's typically administered daily for the first 14 days of a 28-day cycle. Subsequent cycles usually involve daily injections for the first 10 days of a 28-day cycle. Dosage frequency is determined by your doctor based on your individual response.
Univone 1.5mg Injection treats amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease causing muscle weakness and atrophy due to nerve cell death. It slows the progression of nerve damage and associated ALS symptom worsening.
Tell your doctor or pharmacist if you're allergic to edaravone, sodium bisulfite, other medications, or any Univone 1.5mg Injection ingredient. Before starting edaravone, inform your doctor of all medications you take or plan to take, including prescriptions, over-the-counter drugs, vitamins, and supplements; dosage adjustments or side effect monitoring may be needed. Also, tell your doctor about any history of asthma, and if you are pregnant, plan to become pregnant, or are breastfeeding. Contact your doctor immediately if you become pregnant during treatment.
While ALS prevention remains unproven due to a lack of supporting studies, mitigating risk factors may lower the likelihood of developing the disease. Known risk factors include smoking, pesticide and insecticide exposure, and, according to some reports, military service.
People of Caucasian and non-Hispanic descent have the highest incidence of amyotrophic lateral sclerosis (ALS). Between 5 and 10 percent of ALS cases are inherited. Onset can occur at any age, though symptoms typically appear between ages 55 and 75. Men are slightly more prone than women, but this difference lessens with age. Research also indicates that military veterans may have a 1.5 to 2 times greater risk due to potential wartime toxin exposure.
Exposure to toxins during combat or intense physical exertion may contribute to a heightened ALS risk among veterans and athletes.
ALS often begins with subtle muscle symptoms: twitching in limbs or tongue, cramps, stiffness, and weakness in an arm, leg, neck, or diaphragm. Speech may become slurred or nasal, and swallowing difficult. Many first notice hand or arm weakness, hindering tasks like buttoning a shirt or turning a key. Alternatively, leg weakness may be the initial symptom, causing awkward gait, tripping, or stumbling.
Univone 1.5mg Injection
600
MRP 695
13% off